Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

Completed · Not applicable

Conditions studied: Uterine Cervical Neoplasms, Ovarian Neoplasms, Gynecologic Neoplasms, Fallopian Tube Neoplasms, Vulvar Neoplasms, Vaginal Neoplasms, Peritoneal Neoplasms

In brief

To evaluate whether formal referral to The Symptom Management and Supportive Care Clinic improves symptom burden in advanced stage or recurrent gynecologic oncology chemotherapy patients compared with symptom management performed by the primary gynecologic oncologist.

Key facts

Study ID

NCT02786524

Run by

University of Michigan

People needed

107

Starts

2016-02-15

Expected to finish

2017-10-31

Last updated by the study team

2019-03-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• 18 years of age or older
• Diagnosis of Stage III, IV, or recurrent gynecologic malignancy (Uterine, Ovarian, Cervical, Vulvar, Vaginal, Fallopian Tube, Primary Peritoneal)
• Receiving active intravenous, intraperitoneal, or oral chemotherapy
• Patient at University of Michigan Gynecologic Oncology Clinic

You may not qualify if…

• Male
• Less than 18 years of age
• Patients without a diagnosis of a gynecologic malignancy
• Patients not receiving intravenous, intraperitoneal or oral chemotherapy at the time of enrollment
• Patients receiving radiation therapy with chemo-sensitization.

Where it is running

• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.